4.7 Article

Evidence for a Long-Lasting Compulsive Alcohol Seeking Phenotype in Rats

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 43, Issue 4, Pages 728-738

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2017.105

Keywords

-

Funding

  1. Medical Research Council [G1002231]
  2. GlaxoSmithKline (GSK) [GSK1521498]
  3. NIAAA [R24 AA015512]
  4. GSK
  5. Lilly
  6. Lundbeck
  7. Medical Research Council [G1002231, MR/N02530X/1, G1000183, G0401099] Funding Source: researchfish
  8. National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish
  9. MRC [G1000183, MR/N02530X/1, G1002231, G0401099] Funding Source: UKRI

Ask authors/readers for more resources

Excessive drinking to intoxication is the major behavioral characteristic of those addicted to alcohol but it is not the only one. Indeed, individuals addicted to alcohol also crave alcoholic beverages and spend time and put much effort into compulsively seeking alcohol, before eventually drinking large amounts. Unlike this excessive drinking, for which treatments exist, compulsive alcohol seeking is therefore another key feature of the persistence of alcohol addiction since it leads to relapse and for which there are few effective treatments. Here we provide novel evidence for the existence in rats of an individual vulnerability to switch from controlled to compulsive, punishment-resistant alcohol seeking. Alcohol-preferring rats given access to alcohol under an intermittent 2-bottle choice procedure to establish their alcohol-preferring phenotype were subsequently trained instrumentally to seek and take alcohol on a chained schedule of reinforcement. When stable seeking-taking performance had been established, completion of cycles of seeking responses resulted unpredictably either in punishment (0.45 mA foot-shock) or the opportunity to make a taking response for access to alcohol. Compulsive alcohol seeking, maintained in the face of the risk of punishment, emerged in only a subset of rats with a predisposition to prefer and drink alcohol, and was maintained for almost a year. We show further that a selective and potent mu-opioid receptor antagonist (GSK1521498) reduced both alcohol seeking and alcohol intake in compulsive and non-compulsive rats, indicating its therapeutic potential to promote abstinence and prevent relapse in individuals addicted to alcohol.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available